Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.50 |
| ▸ | CHRND | Q07001 | 7/20 | 0.46 |
| ▸ | CHRNA1 | P02708 | 3/20 | 0.46 |
| ▸ | CHRNG | P07510 | 3/20 | 0.46 |
| ▸ | CHRNB1 | P11230 | 3/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.45 |
| ▸ | GRIA1 | P42261 | 6/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19211966 | 0.99 | FOLH1 (0.49) | FOLH1CHRNDCHRNA1CHRNGCHRNB1 | |
| Pentetic Acid SCHEMBL9440488 | 0.91 | SLC15A2 (0.51) | CHRNDCHRNA1CHRNGCHRNB1NTSR1 | |
| Hydrochloric Acid SCHEMBL2259134 | 0.83 | CHRND (0.49) | CHRNDCHRNA1CHRNGCHRNB1CTSL | |
| SCHEMBL9318061 | 0.80 | SLC15A2 (0.60) | CHRNDCHRNA1CHRNGCHRNB1GRIA1 | |
| SCHEMBL9318080 | 0.80 | SLC15A2 (0.60) | CHRNDCHRNA1CHRNGCHRNB1GRIA1 | |
| SCHEMBL7122844 | 0.80 | SLC15A2 (0.59) | CHRNDCHRNA1CHRNGCHRNB1GRIA1 | |
| SCHEMBL7122854 | 0.80 | SLC15A2 (0.59) | CHRNDCHRNA1CHRNGCHRNB1GRIA1 | |
| SCHEMBL30090470 | 0.79 | NPY4R (0.62) | CHRNDCHRNA1CHRNGCHRNB1 | |
| SCHEMBL29822475 | 0.77 | MME (0.56) | FOLH1CHRNDCHRNA1CHRNGCHRNB1 | |
| SCHEMBL9715437 | 0.76 | CHRND (0.44) | CHRNDCHRNA1CHRNGCHRNB1GRIA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2904 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3533863-B1 | PROCESS FOR REDUCING UNWANTED CULTURE BYPRODUCTS IN CELL CULTURE MEDIUM | SAMSUNG BIOEPIS CO LTD (KR) | 2026-03-25 | — | — | EP | claimed |
| US-20260028685-A1 | Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids | UNIV COLORADO REGENTS (US) | 2026-01-29 | — | — | US | claimed |
| EP-3894839-B1 | SYSTEM SUITABILITY METHOD FOR USE WITH PROTEIN CONCENTRATION DETERMINATION BY SLOPE | AMGEN INC (US) | 2026-01-28 | — | — | EP | claimed |
| EP-3765857-B1 | SEQUENTIAL DIGESTION OF POLYPEPTIDES FOR MASS SPECTROMETRIC ANALYSIS | AMGEN INC (US) | 2025-12-10 | — | — | EP | claimed |
| EP-4611839-A1 | WOUND CLEANSING JET | Aurena Laboratories Holding AB (SE) | 2025-09-10 | — | — | EP | claimed |
| EP-3738611-B1 | DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS | BioNTech SE (DE) | 2025-09-03 | — | — | EP | claimed |
| EP-4384551-A2 | COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS BY TARGETING IGSF8 | Shanghai Xunbaihui Biotechnology Co., Ltd. (CN) | 2024-06-19 | — | — | EP | claimed |
| US-12000775-B2 | System suitability method for use with protein concentration determination by slope | AMGEN INC. (US) | 2024-06-04 | — | — | US | claimed |
| WO-2024094828-A1 | WOUND CLEANSING JET | AURENA LABORATORIES HOLDING AB (SE) | 2024-05-10 | — | — | WO | claimed |
| EP-3662287-B1 | SYSTEMS AND METHODS FOR REAL TIME PREPARATION OF A POLYPEPTIDE SAMPLE FOR ANAYLSIS WITH MASS SPECTROMETRY | AMGEN INC (US) | 2024-02-28 | — | — | EP | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20060018934-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20050055174-A1 | Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures | V TARGET LTD. | 2005-03-10 | — | — | US | claimed |
| US-20040253177-A1 | Fatty acid derivatives; tissue-targeted therapy; tomography; cardiovascular disorders; liver disorders; kits | GENERAL HOSPITAL CORPORATION, THE | 2004-12-16 | — | — | US | claimed |
| WO-2004093650-A2 | METHOD FOR MONITORING BLOOD FLOW AND METABOLIC UPTAKE IN TISSUE WITH RADIOLABELED ALKANOIC ACID | THE GENERAL HOSPITAL CORPORATION (US) | 2004-11-04 | — | — | WO | claimed |
| JP-2004512502-A | — | — | 2004-04-22 | — | — | JP | claimed |
| US-20040015075-A1 | Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures | Spectrum Dynamics Medical Limited (VG) | 2004-01-22 | — | — | US | claimed |
| CN-1469720-A | Radioactive emission detector with position tracking system and its application in medical system and medical process | V-Ŀ�꼼������˾ | 2004-01-21 | — | — | CN | claimed |
| EP-1326531-A2 | RADIOACTIVE EMISSION DETECTOR EQUIPPED WITH A POSITION TRACKING SYSTEM AND UTILIZATION THEREOF WITH MEDICAL SYSTEMS AND IN MEDICAL PROCEDURES | V-Target Technologies Ltd. (IL) | 2003-07-16 | — | — | EP | claimed |
| WO-2002016965-A2 | RADIOACTIVE EMISSION DETECTOR | V-TARGET TECHNOLOGIES LTD. (IL) | 2002-02-28 | — | — | WO | claimed |